Jacobi Capital Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-300
Closed -$5K 1044
2018
Q1
$5K Hold
300
﹤0.01% 810
2017
Q4
$4K Hold
300
﹤0.01% 805
2017
Q3
$6K Hold
300
﹤0.01% 724
2017
Q2
$7K Hold
300
﹤0.01% 627
2017
Q1
$6K Buy
+300
New +$6.7K ﹤0.01% 528

Other funds holding PGEN

Jacobi Capital Management's PGEN Position: Q2 2018 in Review

Jacobi Capital Management sold out of Precigen (PGEN) in Q2 2018, closing a stake of 300 shares — an estimated $5K sold.

Jacobi Capital Management first reported a position in PGEN in Q1 2017 and held it in 5 quarters. The position peaked at $7K in Q2 2017. 166 funds tracked by Wall St. Rank hold PGEN as of Q2 2018.

  • Jacobi Capital Management reported no remaining Precigen position as of Q2 2018 after selling out during the quarter.
  • Jacobi Capital Management sold 300 Precigen shares in Q2 2018, an estimated $5K.
  • Jacobi Capital Management first reported a position in Precigen in Q1 2017 and held it in 5 quarters.
  • Jacobi Capital Management's Precigen position peaked at $7K in Q2 2017.
  • 166 funds tracked by Wall St. Rank held Precigen as of Q2 2018.

Based on Jacobi Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.